Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Today's Pre-Market Movers and Top Ratings
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Biggest Stock Movers Friday: BB, BMY, and More
Bristol-Myers Wins FDA Nod for First-of-its-kind Antipsychotic
Exact Sciences, Quanterix Extend Slide After Medicare Rates
Fulcrum Therapeutics Swings up 17% on Pfizer Sickle Cell Drug Setback